BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19560745)

  • 1. Oncolytic viral therapy of malignant glioma.
    Parker JN; Bauer DF; Cody JJ; Markert JM
    Neurotherapeutics; 2009 Jul; 6(3):558-69. PubMed ID: 19560745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Virotherapy for the Treatment of Malignant Glioma.
    Foreman PM; Friedman GK; Cassady KA; Markert JM
    Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.
    Zemp FJ; Corredor JC; Lun X; Muruve DA; Forsyth PA
    Cytokine Growth Factor Rev; 2010; 21(2-3):103-17. PubMed ID: 20483653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
    Shah AC; Benos D; Gillespie GY; Markert JM
    J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruses, gene therapy and stem cells for the treatment of human glioma.
    Kyritsis AP; Sioka C; Rao JS
    Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
    Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS
    Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic HSV-1 for the treatment of brain tumours.
    Markert JM; Parker JN; Buchsbaum DJ; Grizzle WE; Gillespie GY; Whitley RJ
    Herpes; 2006 Nov; 13(3):66-71. PubMed ID: 17147910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of viral therapy for malignant gliomas.
    Piccioni DE; Kesari S
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1297-305. PubMed ID: 24138481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viruses for treatment of malignant brain tumours.
    Rainov NG; Ren H
    Acta Neurochir Suppl; 2003; 88():113-23. PubMed ID: 14531569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promises of oncolytic viral therapy for adult and children with brain glioma.
    Patiño-García A; Alonso MM; Gállego Pérez-Larraya J
    Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncolytic viruses in the therapy of gliomas].
    Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells.
    White MC; Frampton AR
    Cancer Gene Ther; 2013 Feb; 20(2):88-93. PubMed ID: 23306611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain tumor therapy using replication--competent virus vectors].
    Todo T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():504-9. PubMed ID: 16201572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.